GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients
Pharmaceutical Technology
JULY 14, 2025
How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. MAXSHOT.PL via Shutterstock. A decision by the FDA is expected in H1 2026.
Let's personalize your content